1. Home
  2. IMRN vs SDOT Comparison

IMRN vs SDOT Comparison

Compare IMRN & SDOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMRN
  • SDOT
  • Stock Information
  • Founded
  • IMRN 1994
  • SDOT 2014
  • Country
  • IMRN Australia
  • SDOT United States
  • Employees
  • IMRN N/A
  • SDOT N/A
  • Industry
  • IMRN Biotechnology: Pharmaceutical Preparations
  • SDOT Restaurants
  • Sector
  • IMRN Health Care
  • SDOT Consumer Discretionary
  • Exchange
  • IMRN Nasdaq
  • SDOT Nasdaq
  • Market Cap
  • IMRN 15.0M
  • SDOT 14.2M
  • IPO Year
  • IMRN N/A
  • SDOT 2020
  • Fundamental
  • Price
  • IMRN $1.90
  • SDOT $3.38
  • Analyst Decision
  • IMRN Strong Buy
  • SDOT Hold
  • Analyst Count
  • IMRN 1
  • SDOT 1
  • Target Price
  • IMRN $5.00
  • SDOT N/A
  • AVG Volume (30 Days)
  • IMRN 4.7K
  • SDOT 28.3K
  • Earning Date
  • IMRN 03-03-2025
  • SDOT 03-19-2025
  • Dividend Yield
  • IMRN N/A
  • SDOT N/A
  • EPS Growth
  • IMRN N/A
  • SDOT N/A
  • EPS
  • IMRN N/A
  • SDOT 0.35
  • Revenue
  • IMRN $3,271,194.00
  • SDOT $655,938,000.00
  • Revenue This Year
  • IMRN N/A
  • SDOT $1.20
  • Revenue Next Year
  • IMRN N/A
  • SDOT $29.55
  • P/E Ratio
  • IMRN N/A
  • SDOT $9.70
  • Revenue Growth
  • IMRN 171.67
  • SDOT N/A
  • 52 Week Low
  • IMRN $1.65
  • SDOT $2.24
  • 52 Week High
  • IMRN $5.96
  • SDOT $7.00
  • Technical
  • Relative Strength Index (RSI)
  • IMRN 43.76
  • SDOT 60.49
  • Support Level
  • IMRN $1.89
  • SDOT $3.01
  • Resistance Level
  • IMRN $2.05
  • SDOT $2.95
  • Average True Range (ATR)
  • IMRN 0.08
  • SDOT 0.19
  • MACD
  • IMRN -0.02
  • SDOT 0.10
  • Stochastic Oscillator
  • IMRN 3.85
  • SDOT 98.85

About IMRN Immuron Limited

Immuron Ltd is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel class of immunomodulator polyclonal antibodies to treat liver diseases, infectious diseases and other immune-mediated diseases, such as colitis. The company's product, IMM-124E, is a proprietary immunomodulatory agent targeted at GI immune-mediated diseases including fatty liver diseases. The company functions in two segments namely, Research and Development and Hyperimmune products.

About SDOT Sadot Group Inc.

Sadot Group Inc operates in the food supply chain sector, connecting producers and consumers across the globe, delivering agri-commodities from producing geographies such as the Americas, Africa, and the Black Sea to consumer markets in Southeast Asia, China, and the Middle East/North Africa (MENA) region. Its reportable segment includes Sadot food service and Sadot agri-foods. The key revenue is coming from the Sadot agri-foods segment which engaged in farming, commodity trading, and shipping of food and feed.

Share on Social Networks: